Bowen David G, Shoukry Naglaa H, Grakoui Arash, Fuller Michael J, Cawthon Andrew G, Dong Christine, Hasselschwert Dana L, Brasky Kathleen M, Freeman Gordon J, Seth Nilufer P, Wucherpfennig Kai W, Houghton Michael, Walker Christopher M
Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, 700 Childrens Dr., Columbus, OH 43205, USA.
J Virol. 2008 May;82(10):5109-14. doi: 10.1128/JVI.00060-08. Epub 2008 Mar 12.
The inhibitory receptor programmed death-1 (PD-1) is present on CD8(+) T cells in chronic hepatitis C virus (HCV), but expression patterns in spontaneously resolving infections are incompletely characterized. Here we report that PD-1 was usually absent on memory CD8(+) T cells from chimpanzees with resolved infections, but sustained low-level expression was sometimes observed in the absence of apparent virus replication. PD-1-positive memory T cells expanded and displayed antiviral activity upon reinfection with HCV, indicating conserved function. This animal model should facilitate studies of whether PD-1 differentially influences effector and memory T-cell function in resolved versus persistent human infections.
抑制性受体程序性死亡1(PD-1)存在于慢性丙型肝炎病毒(HCV)感染患者的CD8(+) T细胞上,但在自然清除感染中的表达模式尚未完全明确。在此我们报告,在感染已清除的黑猩猩的记忆性CD8(+) T细胞上,PD-1通常并不存在,但在无明显病毒复制的情况下,有时也会观察到其持续低水平表达。PD-1阳性记忆性T细胞在再次感染HCV后会扩增并展现出抗病毒活性,表明其功能保守。该动物模型应有助于研究PD-1在人类感染已清除与持续存在状态下对效应性和记忆性T细胞功能的影响是否存在差异。